Search Videos and More
News
Clinical Trials at Miami Cancer Institute Investigate Novel Approaches for Treating Blood Cancers
A new clinical trial awaiting final preparations at Miami Cancer Institute, part of Baptist Health, will test premanufactured blood products that researchers hope will lead to “off the shelf” solutions for some patients who require chimeric antigen-specific T-cell therapy to treat their blood cancers.
News
Blood and Marrow Transplantation Program Achieves Accreditation for APP Fellowship Program
Baptist Health Miami Cancer Institute's Malignant Hematology/Blood and Bone Marrow Transplant Fellowship has earned accreditation with distinction as an Advanced Practice Provider Fellowship Program by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation in Practice Transition Programs.
News
Dr. Mehta on the Advantages of MRI-Guided Adaptive Radiotherapy in Cancer Care
Minesh Mehta, M.D., chief of radiation oncology and deputy director of Baptist Health Miami Cancer Institute , discusses the potential utility of radiotherapy, including how the introduction of MRI-guided adaptive radiation therapy systems is improving precision and outcomes across cancer care.
News
Integrated Oncology Research Explores New Pathways for Treatment of Primary and Metastatic Brain Cancer
At Baptist Health Miami Cancer Institute, parallel lines of research are underway to develop transformative approaches to maximize tumor control while protecting neurocognitive function during brain tumor treatment.
News
2024 Caring for Kids with Cancer Symposium
This symposium will provide an update on the latest developments in the management of sarcomas and leukemias including immunotherapy and CAR T-cell therapy.
News
A Surgical Milestone: Miami Cancer Institute First in Southeast Region to Complete Uterine Transposition on Cancer Patient
Miami Cancer Institute, part of Baptist Health South Florida, is the first cancer center to conduct a successful uterine transposition surgery on a cancer patient in the Southeast region.
News
New Drug Extends Survival for Late-Stage Prostate Cancer Patients
Baptist Health Miami Cancer Institute is among the first cancer centers in the region to offer an innovative radiopharmaceutical therapy that can extend survival and increase quality of life for patients with stage 4 metastatic prostate cancer, according to radiation oncologist Adeel Kaiser, M.D.
News
Gallbladder Cancer: Progress and Hope for Future Breakthroughs
For Gallbladder Cancer Awareness Month, Horacio J. Asbun, MD, and Domenech Asbun, MD, shared their thoughts and strategies for treating patients with this disease from the surgical and clinical sides.
News
Study: Ablative Stereotactic Magnetic Resonance-Guided Adaptive Radiation Therapy May Improve Overall Survival in Patients with Pancreatic Cancer
A study co-led by researchers at Miami Cancer Institute, part of Baptist Health South Florida, found that ablative stereotactic magnetic resonance (MR)-guided adaptive radiation therapy may improve local control (LC) and overall survival (OS) in patients with borderline resectable (BRPC) and locally advanced pancreas cancer (LAPC).
News
When Your Patient Needs an Oral Medicine Evaluation
Whether your patient is being treated for cancer, has an autoimmune disease or an inflammatory condition that is causing an oral problem apart from the teeth and gums, they may benefit from an evaluation and treatment by an oral medicine specialist.
News
Miami Cancer Institute Leads First-in-World Brain Metastasis Trial
Baptist Health Miami Cancer Institute is leading a groundbreaking clinical trial that is studying the use of a new medication combined with stereotactic radiosurgery to combat metastatic brain cancer.
News
Miami Cancer Institute Publication Analyzes Role of Tissue-Agnostic Therapies for the Treatment of Primary Brain Tumors
Researchers from Miami Cancer Institute, part of Baptist Health South Florida, recently published a study in Trends in Cancer that analyzes the use of tissue-agnostic therapeutics in patients with primary brain tumors (PBTs). The publication describes the current and potential impact of tissue-agnostic therapies on the management of PBTs. As part of the publication, the researchers discuss data from clinical trials of tissue-agnostic targets for PBTs in the context of challenges in managing these tumors. They also describe additional tissue-agnostic targets that hold promise for benefiting patients with PBTs.